Effectiveness of the 2023-2024 Formulation of the COVID-19 Messenger RNA Vaccine.
Saved in:
| Title: | Effectiveness of the 2023-2024 Formulation of the COVID-19 Messenger RNA Vaccine. |
|---|---|
| Authors: | Shrestha NK; Department of Infectious Diseases, Cleveland Clinic, Cleveland, Ohio, USA., Burke PC; Infection Prevention, Cleveland Clinic, Cleveland, Ohio, USA., Nowacki AS; Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA., Gordon SM; Department of Infectious Diseases, Cleveland Clinic, Cleveland, Ohio, USA. |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Aug 16; Vol. 79 (2), pp. 405-411. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1537-6591 |
|---|---|
| DOI: | 10.1093/cid/ciae132 |
